Overcoming tumor heterogeneity in the molecular diagnosis of urological cancers

References

• Aktipis CA, Nesse RM. Evolutionary foundations for cancer biology. Evol Appl 2013;6:144-59
   PubMed Web of Science ®Google Scholar
• Nguyen LV, Vanner R, Dirks P, Eaves CJ. Cancer stem cells: an evolving concept. Nat Rev Cancer 2012;12:133-43
   PubMed Web of Science ®Google Scholar
• Kannan N, Nguyen L, Eaves C. Integrin B3 links therapy resistance and cancer stem cell properties. Nat Cell Biol 2014;16:397-9
   Google Scholar
• Zhou A, Owens C, Cosar E, Jiang Z. Clinical implications of current developments in genitourinary pathology. Arch Pathol Lab Med 2013;137:887-93
   Google Scholar
• Guancia E, Bellmunt J, Shuyuan Y, et al. The evolving understanding of microRNA in bladder cancer. Urol Oncol 2014;32:41; e31-41.e40
   Google Scholar
• Xylinas E, Cha EK, Kluth LA, et al. Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder. J Urol 2014;191:830-41
   Google Scholar
• Janku F. Tumor heterogeneity in the clinic: is it a real problem? Ther Adv Med Oncol 2014;6:43-51
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C, Kotsianti A, Verbel DA, et al. Improved prediction of prostate cancer recurrence through systems pathology. J Clin Invest 117:1876-83.2007
   PubMed Web of Science ®Google Scholar
• Donovan MJ, Hamann S, Clayton M, et al. A systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy. J Clin Oncol 26:3923-9.2008
   Google Scholar
• Donovan MJ, Khan FM, Fernandez G, et al. Personalized prediction of tumor response and cancer progression on prostate needle biopsy. J Urol 182:123-30.2009
   Google Scholar
• Vuonq D, Simposon PT, Green B, et al. Molecular classification of breast cancer. Virchows Arch 2014;465(1):1-14
   Google Scholar
• Wong YN, Ferraldeschi R, Attard G, de Bono J. Evolution of androgen receptor targeted therapy for advanced prostate cancer. Nat Rev Clin Oncol 2014;11:365-76
   PubMed Web of Science ®Google Scholar
• Lee-Ying R, Lester R, Heng DY. Current management and future perspectives of metastatic renal cell carcinoma. Int J Urol 2014;21(9):847-55
   Google Scholar
• Parker BC, Engels M, Annala M, Zhang W. Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours. J Pathol 2014;232:4-15
   PubMed Web of Science ®Google Scholar
• Chatterjee P, Choudhary GS, Singh K, et al. PARP inhibition sensitizes to low does-rate radiation TMPRSS2-ERG fusion gene-expressing and PTEN-deficient prostate cancer cells. PLoS One 2013;8:e60408
   Google Scholar
• Ogino S, Fuchs CS, Giovannucci E. How many molecular subtypes? Implications of the unique tumor principle in personalized medicine. Expert Rev Mol Diagn 2012;12:621-8
   PubMed Web of Science ®Google Scholar
• Rodriques DN, Butler LM, Estelles DL, de Bono JS. Molecular pathology and prostate cancer therapeutics: from biology to bedside. J Pathol 2014;232:178-84
   Google Scholar
• Powles T, Vogelzang N, Fine G, et al. Inhibition of PD-L1 by MPDL3280A and clinical activity in pts with metastatic urothelial bladder cancer (UBC). J Clin Oncol 2014;32(5 Suppl):abstract 5011
   Google Scholar
• Sweeney C, Yu-Hui C, Carducci M, et al. Impact on overall survival (OS) with chemohormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): An ECOG-led phase III randomized trial. J Clin Oncol 2014;32:abstract LBA2
   Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30
   PubMed Web of Science ®Google Scholar
• Shuch B, Amin A, Armstrong A, et al. Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. Eur Urol 2014. [Epub ahead of print]
   Google Scholar
• Gerlinger M, Rowan A, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012;366:883-92
   PubMed Web of Science ®Google Scholar
• Topalian SL, Hodi FS, Brahmer JR, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012;266:2443-54
   Google Scholar
• Upton MP, Parker RA, Youmans A, et al. Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy. J Immunother 2005;28:488-95
   PubMed Web of Science ®Google Scholar
• Bellmunt J, The B, Tortora G, Rosenberg J. Molecular targets on the horizon for kidney and urothelial cancer. Nat Rev Clin Onc 2013;10:557-70
   Google Scholar
• Barberi CE, Tomlins SA. The prostate cancer genome: perspectives and potential. Urol Oncol 2014;32:53; e15-22
   Google Scholar
• Fraser M, Berlin A, Bristown RG, van der Kwast T. Genomic, pathological, and clinical heterogeneity as drives of personalized medicine in prostate cancer. Urol Oncol 2014. [Epub ahead of print]
   Google Scholar
• Haffner MC, Mosbruger T, Esopi DM, et al. Tracking the clonal origin of lethal prostate cancer. J Clin Invest 2013;123:4918-22
   PubMed Web of Science ®Google Scholar
• Eisenberg MS, Boorjian SA, Cheville JC, et al. The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer. J Urol 2013;190:2005-10
   PubMed Web of Science ®Google Scholar
• Donovan MJ, Khan FH, Powell D, et al. Previously developed systems-based model (Prostate Px+) identifies favorable-risk prostate cancer for men enrolled in active surveillance program. J Urol 2011;185:e517-18
   Google Scholar
• Domingo-Domenech J, Vidal SJ, Rodriquez-Bravo V, et al. Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch-and hedgehog-dependent tumor-initiating cells. Cancer Cell 2012;22:373-88
   PubMed Web of Science ®Google Scholar
• Ullal A, Peterson V, Agasti S, et al. Cancer cell profiling by barcoding allows multiplexed protein analysis in fine-needle aspirates. Sci Transl Med 2014;219:1-11
   Google Scholar
• Giesen C, Wang H, Schapiro D, et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat Methods 2014;11:417-22
   PubMed Web of Science ®Google Scholar
• Wolf C, Jarutat T, Harring S, et al. Determination of phosphorylated proteins in tissue specimens requires high-quality samples collected under stringent conditions. Histopathology 2014;64:431-44
   PubMed Web of Science ®Google Scholar
• Abel EJ, Bauman TM, Weiker M, et al. Analysis and validation of tissue biomarkers of renal cell carcinoma using automated high-throughput evaluation of protein expression. Hum Pathol 2014;45:1092-9
   Google Scholar
• Steurer S, Singer JM, Rink M, et al. MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarrays. Urol Oncol 2014. [Epub ahead of print]
   Google Scholar
• Lianidou ES, Strati A, Markou A. Circulating tumor cells as promising novel biomarkers in solid cancers. Crit Rev Clin Lab Sci 2014;51:160-71
   PubMed Web of Science ®Google Scholar
• Gazzaniga P, Berardinis E, Raimondi C, Gradilone A. Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer. Int J Cancer 2014;135(8):1978-82
   PubMed Web of Science ®Google Scholar
• Khan MI, Czarnecka AM, Duchnowska R, et al. Metastasis-initiating cells in renal cancer. Curr Signal Transduct Ther 2014;8:240-6
   Google Scholar
• Antonarakis E, Lu C, Wang H, et al. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N Engl J Med 2014;371(11):1028-38
   PubMed Web of Science ®Google Scholar
• Marzese D, Hirose H, Hoon D. Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients. Expert Rev Mol Diagn 2013;13:827-44
   PubMed Web of Science ®Google Scholar
• Esposito A, Bardelli A, Criscitiello C, et al. Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical prospective and research opportunities. Cancer Treatment Rev. Cancer Treat Rev 2014;40:648-55
   PubMed Web of Science ®Google Scholar
• Ralla B, Stephan C, Meller S, et al. Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies. Crit Rev Clin Lab Sci 2014;51(4):200-31
   PubMed Web of Science ®Google Scholar
• Goodison S, Rosser CJ, Urquidi V. Bladder cancer detection and monitoring: assessment of urine-and blood-based marker tests. Mol Diagn Ther 2013;17:71-84
   PubMed Web of Science ®Google Scholar
• Hauser S, Zahalka T, Fechner G, et al. Serum DNA methylation in patients with kidney cancer: results of a prospective study. Anticancer Res 2013;33:4651-6
   PubMed Web of Science ®Google Scholar
• Wroclawski ML, Serpa-Neto A, Fonseca FL, et al. Cell-free plasma DNA as biochemical biomarker for the diagnosis and follow-up of prostate cancer patients. Tumour Biol 2013;34:2921-7
   PubMed Web of Science ®Google Scholar
• Skog J, Wurdinger T, van Rijn S, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanisms of genetic exchange between cells. Nat Cell Biol 2007;9:654-9
   Google Scholar
• Mizutani K, Terazawa R, Kameyama K, et al. Isolation of prostate cancer-related exosomes. Anticancer Res 2014;34:3419-23
   PubMed Web of Science ®Google Scholar
• Nilsson J, Skog J, Nordstrand A, et al. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer 2009;100:1603-7
   PubMed Web of Science ®Google Scholar
• Russo L, Bate K, Motamedinia P, et al. Urinary exosomes as a stable source of mRNA for prostate cancer analysis. J Clin Oncol 2012(Suppl 5):abstract 174
   Google Scholar
• McKiernan J, Saltzstein D, Cochran J, et al. Urinary exosomes/microvesicles as a non-invasive platform for prostate cancer analysis. J Urol 2013;189(Suppl):e842
   Google Scholar
• Motamedinia P, Scott A, Bate K, et al. Preoperative urinary exosome detection of TMPRSS2:ERG mRNA closely correlates with tissue expression at radical prostatectomy. J Urol 2013;187(Suppl):e850-1
   Google Scholar
• Sun Y, Liu J. Potential of cancer cell-derived exosomes in clinical application: a review of recent research advances. Clin Ther 2014;36(6):863-72
   Web of Science ®Google Scholar